In Phase A, individuals will get various doses and schedules of oral ABBV-744 tablet to detect Protected dosing regimen. More contributors is going to be enrolled with the discovered monotherapy dosign program. In Segment B, participants will obtain oral ruxolitinib and ABBV-744 might be provided as "insert-on" therapy. In Phase https://abbv-744brd4inhibitorcanc35689.blogscribble.com/32004451/indicators-on-clinical-trial-recruitment-for-abbv-744-study-you-should-know